| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Consensus statement on the pathology of IgG4-related disease.
|
Mod Pathol
|
2012
|
9.01
|
|
2
|
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.
|
Arthritis Rheum
|
2012
|
4.27
|
|
3
|
Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis.
|
Kidney Int
|
2010
|
3.13
|
|
4
|
IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights.
|
J Rheumatol
|
2010
|
2.18
|
|
5
|
Proposal for diagnostic criteria for IgG4-related kidney disease.
|
Clin Exp Nephrol
|
2011
|
2.12
|
|
6
|
Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System.
|
Blood
|
2006
|
2.11
|
|
7
|
Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells.
|
J Biol Chem
|
2004
|
1.63
|
|
8
|
IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century.
|
J Clin Exp Hematop
|
2011
|
1.58
|
|
9
|
Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan.
|
Int J Rheumatol
|
2012
|
1.56
|
|
10
|
Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression.
|
J Immunol
|
2002
|
1.53
|
|
11
|
Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.
|
J Exp Med
|
2005
|
1.46
|
|
12
|
An early view of the international Sjögren's syndrome registry.
|
Arthritis Rheum
|
2009
|
1.43
|
|
13
|
Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.
|
Arthritis Rheum
|
2011
|
1.42
|
|
14
|
Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease.
|
Int J Rheumatol
|
2012
|
1.39
|
|
15
|
Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis.
|
Arthritis Rheum
|
2004
|
1.32
|
|
16
|
Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
|
Autoimmunity
|
2006
|
1.27
|
|
17
|
Intravascular large B cell lymphoma: proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition.
|
Int J Hematol
|
2009
|
1.21
|
|
18
|
Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice.
|
J Biol Chem
|
2010
|
1.16
|
|
19
|
DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteins.
|
FEBS J
|
2010
|
1.10
|
|
20
|
Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8.
|
Intern Med
|
2006
|
1.10
|
|
21
|
Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry.
|
Arthritis Care Res (Hoboken)
|
2012
|
1.10
|
|
22
|
Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
|
J Clin Exp Hematop
|
2013
|
1.08
|
|
23
|
A new clinical entity: IgG4-related disease (IgG4-RD) discovered in the 21st century.
|
Intern Med
|
2012
|
1.03
|
|
24
|
Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis.
|
Cancer Res
|
2004
|
1.03
|
|
25
|
Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.
|
Anticancer Res
|
2011
|
1.01
|
|
26
|
Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway.
|
J Biol Chem
|
2012
|
1.00
|
|
27
|
Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: a retrospective multicenter study.
|
Arthritis Res Ther
|
2014
|
1.00
|
|
28
|
Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with phosphatidylinositol 3-kinase and phospholipase C-gamma following CD2 stimulation.
|
Eur J Immunol
|
2002
|
0.98
|
|
29
|
The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis.
|
Rheumatology (Oxford)
|
2013
|
0.96
|
|
30
|
Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.
|
Am J Pathol
|
2006
|
0.96
|
|
31
|
Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4.
|
FEBS Lett
|
2012
|
0.95
|
|
32
|
Immunohistochemical Characteristics of IgG4-Related Tubulointerstitial Nephritis: Detailed Analysis of 20 Japanese Cases.
|
Int J Rheumatol
|
2012
|
0.94
|
|
33
|
Ceramide increases oxidative damage due to inhibition of catalase by caspase-3-dependent proteolysis in HL-60 cell apoptosis.
|
J Biol Chem
|
2003
|
0.94
|
|
34
|
Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.
|
Cancer Res
|
2004
|
0.93
|
|
35
|
Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.
|
Int Immunol
|
2008
|
0.90
|
|
36
|
Sphingomyelin synthase 1-generated sphingomyelin plays an important role in transferrin trafficking and cell proliferation.
|
J Biol Chem
|
2011
|
0.90
|
|
37
|
Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis.
|
Mod Rheumatol
|
2012
|
0.90
|
|
38
|
Validation of different sets of criteria for the diagnosis of Sjögren's syndrome in Japanese patients.
|
Mod Rheumatol
|
2012
|
0.88
|
|
39
|
Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase.
|
Blood
|
2004
|
0.88
|
|
40
|
Henoch-Schönlein purpura nephritis in a patient with IgG4-related disease: a possible association.
|
Clin Nephrol
|
2013
|
0.88
|
|
41
|
[Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].
|
Brain Nerve
|
2011
|
0.87
|
|
42
|
Regulation of cell migration by sphingomyelin synthases: sphingomyelin in lipid rafts decreases responsiveness to signaling by the CXCL12/CXCR4 pathway.
|
Mol Cell Biol
|
2012
|
0.87
|
|
43
|
Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan.
|
Mod Rheumatol
|
2013
|
0.84
|
|
44
|
IgG4-related skin lesions in a patient with IgG4-related chronic sclerosing dacryoadenitis and sialoadenitis.
|
Intern Med
|
2011
|
0.84
|
|
45
|
IgG4-related tubulointerstitial nephritis and hepatic inflammatory pseudotumor without hypocomplementemia.
|
Intern Med
|
2011
|
0.84
|
|
46
|
Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
|
J Autoimmun
|
2009
|
0.84
|
|
47
|
Membrane-bound form of fractalkine induces IFN-gamma production by NK cells.
|
Eur J Immunol
|
2003
|
0.83
|
|
48
|
Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial.
|
Mod Rheumatol
|
2008
|
0.82
|
|
49
|
CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice.
|
Int Immunol
|
2012
|
0.82
|
|
50
|
Cellular heat acclimation regulates cell growth, cell morphology, mitogen-activated protein kinase activation, and expression of aquaporins in mouse fibroblast cells.
|
Cell Physiol Biochem
|
2012
|
0.82
|
|
51
|
Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro.
|
Int Immunol
|
2005
|
0.81
|
|
52
|
Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan.
|
Eur J Haematol
|
2006
|
0.81
|
|
53
|
Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis.
|
Anticancer Res
|
2010
|
0.81
|
|
54
|
Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
|
J Immunol
|
2014
|
0.81
|
|
55
|
H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts.
|
J Biol Chem
|
2002
|
0.81
|
|
56
|
Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial.
|
Mod Rheumatol
|
2007
|
0.81
|
|
57
|
[Identification of human salivary stem cells from cultured labial minor salivary cells].
|
Nihon Rinsho Meneki Gakkai Kaishi
|
2007
|
0.80
|
|
58
|
IgG4-Related Disease.
|
Int J Rheumatol
|
2013
|
0.80
|
|
59
|
[IgG4-related disease-the diagnostic confusion and how to avoid it].
|
Nihon Rinsho Meneki Gakkai Kaishi
|
2009
|
0.80
|
|
60
|
Complete response obtained by bortezomib plus dexamethasone in a patient with relapsed multiple myeloma with multiple plasmacytomas.
|
Anticancer Res
|
2010
|
0.80
|
|
61
|
Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.
|
Anticancer Res
|
2012
|
0.80
|
|
62
|
Skewed production of IL-6 and TGFβ by cultured salivary gland epithelial cells from patients with Sjögren's syndrome.
|
PLoS One
|
2012
|
0.80
|
|
63
|
Palliative radiotherapy with 1 x 8 Gy using conformal radiotherapy for chemotherapy-refractory, recurrent, aggressive lymphomas.
|
Jpn J Radiol
|
2010
|
0.80
|
|
64
|
Increased expression of ganglioside GM1 in peripheral CD4+ T cells correlates soluble form of CD30 in Systemic Lupus Erythematosus patients.
|
J Biomed Biotechnol
|
2010
|
0.80
|
|
65
|
Long-term heat exposure prevents hypoxia-induced apoptosis in mouse fibroblast cells.
|
Cell Biochem Biophys
|
2014
|
0.80
|
|
66
|
Increase of ceramide in adriamycin-induced HL-60 cell apoptosis: detection by a novel anti-ceramide antibody.
|
Biochim Biophys Acta
|
2002
|
0.79
|
|
67
|
Induction of HITS, a newly identified family with sequence similarity 107 protein (FAM107B), in cancer cells by heat shock stimulation.
|
Int J Oncol
|
2010
|
0.79
|
|
68
|
Cisplatin augments FAS-mediated apoptosis through lipid rafts.
|
Anticancer Res
|
2010
|
0.79
|
|
69
|
Possible Mechanisms of Lymphoma Development in Sjögren's Syndrome.
|
Curr Immunol Rev
|
2013
|
0.78
|
|
70
|
Cholesterol-dependent induction of dendrite formation by ginsenoside Rh2 in cultured melanoma cells.
|
Int J Mol Med
|
2010
|
0.78
|
|
71
|
Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events.
|
Anticancer Res
|
2011
|
0.78
|
|
72
|
Loss of HITS (FAM107B) expression in cancers of multiple organs: tissue microarray analysis.
|
Int J Oncol
|
2012
|
0.78
|
|
73
|
Prevention of fasting-mediated bone marrow atrophy by leptin administration.
|
Cell Immunol
|
2011
|
0.78
|
|
74
|
[Fractalkine and inflammatory diseases].
|
Nihon Rinsho Meneki Gakkai Kaishi
|
2005
|
0.78
|
|
75
|
Urinary pseudouridine in patients with lymphoma: comparison with other clinical parameters.
|
Clin Chim Acta
|
2006
|
0.78
|
|
76
|
A case of Mikulicz's disease complicated with interstitial nephritis successfully treated by high-dose corticosteroid.
|
Mod Rheumatol
|
2006
|
0.77
|
|
77
|
Inhibitory effects of dietary glucosylceramides on squamous cell carcinoma of the head and neck in NOD/SCID mice.
|
Int J Clin Oncol
|
2010
|
0.77
|
|
78
|
Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.
|
Int Immunol
|
2007
|
0.77
|
|
79
|
Vesnarinone causes oxidative damage by inhibiting catalase function through ceramide action in myeloid cell apoptosis.
|
Mol Pharmacol
|
2002
|
0.77
|
|
80
|
Upregulation of aquaporin expression in the salivary glands of heat-acclimated rats.
|
Sci Rep
|
2013
|
0.77
|
|
81
|
Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
|
Anticancer Res
|
2012
|
0.77
|
|
82
|
High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma.
|
Int J Hematol
|
2011
|
0.76
|
|
83
|
[Very good partial response and long time to progression by short-term bortezomib plus dexamethasone therapy for a patient with relapsed and refractory multiple myeloma-a case report].
|
Gan To Kagaku Ryoho
|
2009
|
0.75
|
|
84
|
MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy.
|
Anticancer Res
|
2009
|
0.75
|
|
85
|
[Analysis of clinical significance of anti-cyclic citrullinated peptide antibody (anti-CCP antibody) in rheumatoid arthritis (RA)].
|
Nihon Rinsho Meneki Gakkai Kaishi
|
2007
|
0.75
|
|
86
|
[Primary neurolymphomatosis of the cervical nerve root].
|
Rinsho Ketsueki
|
2010
|
0.75
|
|
87
|
[IgG4-related disease-a novel disease concept-].
|
Rinsho Ketsueki
|
2011
|
0.75
|
|
88
|
Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma.
|
Am J Hematol
|
2011
|
0.75
|
|
89
|
[Diagnosis and therapy for systemic sclerosis].
|
Nihon Naika Gakkai Zasshi
|
2007
|
0.75
|
|
90
|
["Lipid rafts" for cell activation].
|
Nihon Rinsho Meneki Gakkai Kaishi
|
2003
|
0.75
|
|
91
|
[Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma - a case report].
|
Gan To Kagaku Ryoho
|
2012
|
0.75
|
|
92
|
A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia.
|
Anticancer Res
|
2012
|
0.75
|
|
93
|
[Successful salvage therapy of continuous low-dose irinotecan for a patient with relapsed and refractory diffuse large B-cell lymphoma].
|
Rinsho Ketsueki
|
2005
|
0.75
|